Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inequitable Conduct, Post-Grant Review Still Weigh On Patent Bill Progress

This article was originally published in The Gray Sheet

Executive Summary

Now that a grand compromise has been reached on damages calculation provisions in a Senate patent reform bill, the focus has shifted to what avenues should be available to challenge the validity of issued patents
Advertisement

Related Content

House Panel Takes Closer Look At Patent Reform “Gatekeeper” Provision
House Panel Takes Closer Look At Patent Reform “Gatekeeper” Provision
Senate Panel Passes Patent Bill; Floor Fight Expected
Senate Panel Passes Patent Bill; Floor Fight Expected

Topics

Advertisement
UsernamePublicRestriction

Register

MT027313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel